pone.0284767.t001 - High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria
收藏数据链接：
官方服务：
资源简介：
pone.0284767.t001 - High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria
创建时间：
2023-05-17
